Investigates relationships among late-life depression, modifiable health risks, cognitive decline, and Alzheimer's disease. Integrates clinical assessment, neuropsychological testing, multimodal neuroimaging, and genetics to identify biomarkers and intervention targets for individuals at elevated risk of dementia.